OUR STUDY IS NOW CLOSED, BUT IF YOU HAVE SUDDEN HEARING LOSS IN ONE EAR YOU SHOULD SEEK CARE ASAP AT YOUR LOCAL OTOLARYNGOLOGY / AUDIOLOGY OFFICE

_________________________

What is sudden sensorineural hearing loss?

Study overview

What is intratympanic steroid therapy? (Flash video)


Sudden Sensorineural Hearing Loss (SSNHL) is a medical emergency

We are hoping to learn more with our five year (2004-2009) SSNHL research study sponsored by the NIH-NIDCD. Our recruitment phase is now closed but if you have sudden hearing loss in one ear please seek care from a specialist

Study Chair and Steering Committee Chair: Steven D. Rauch, MD

Site Principal Investigator, Massachusetts Eye and Ear Infirmary: Daniel J. Lee, MD FACS

Senior Study Audiologist: Chris Halpin, PhD,

Department of Otology and Laryngology, Harvard Medical School, Boston, MA

The gold standard treatment for sudden deafness, if caught within two weeks of the onset of the symptoms, is high-dose steroids, taken by mouth.

Evidence now suggests that injection of medication into the middle ear, using a relatively painless, and quick procedure in the clinic, is also effective in treating sudden sensorineural hearing loss without the side effects that can be seen when taking high-dose steroids by mouth.

Download the 2004 AAA research poster here

Download the 2008 article by Dr. Rauch on sudden single-sided deafness in NEJM

Dr. Rauch and the lead center, the Massachusetts Eye and Ear Infirmary, and 16 centers nationwide participated in a 5 year clinical trial sponsored by the National Institute on Deafness and Other Communication Disorders (NIDCD) - National Institutes of Health (NIH).

The study began in December, 2004 and was completed in 2010, and compared high dose oral steroids with intratympanic, or middle-ear injections of a special formulation of steroid medication for the treatment of sudden sensorineural hearing loss.

This Sudden Sensorineural Hearing Loss Multicenter Treatment Trial is the first prospective, randomized clinical trial to compare these two different treatment options.

This multimillion dollar NIDCD/NIH study will provide valuable information to patients, otologists and otolaryngologists, and referring physicians about the most appropriate management of this otologic emergency.

More information about Sudden Sensorineural Hearing Loss Multicenter Treatment Trial can also be found on the NIH website







   
image